Radiofrequency ablation for hepatocellular carcinoma: Assistant techniques for difficult cases

Oncology

Volumn 78, Issue SUPPL. 1, 2010, Pages 94-101

  Inoue, Tatsuo ^a   Minami, Yasunori ^a   Chung, Hobyung ^a   Hayaishi, Sousuke ^a   Ueda, Taisuke ^a   Tatsumi, Chie ^a   Takita, Masahiro ^a   Kitai, Satoshi ^a   Hatanaka, Kinuyo ^a   Ishikawa, Emi ^a   Yada, Norihisa ^a   Hagiwara, Satoru ^a   Ueshima, Kazuomi ^a   Kudo, Masatoshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endoscopic nasobiliary drainage; Pleural effusion; Radiofrequency ablation

Indexed keywords

PERFLUBUTANE; SHU 508;

ADULT; AGED; ARTICLE; ASCITES; B SCAN; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; FEMALE; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77954494288     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315236     Document Type: Article

References (26)

1. Lin SM, Lin CJ, Lin CC, et al: Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma = 4 cm. Gastroenterology 2004; 127: 1714-1723.
2. Livraghi T, Goldberg SN, Lazzaroni S, et al: Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210: 655-661.
3. Rossi S, Di Stasi M, Buscarini E, et al: Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996; 167: 759-768.
4. Teratani T, Yoshida H, Shiina S, et al: Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 2006; 43: 1101-1108.
5. Tateishi R, Shiina S, Teratani T, et al: Percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1000 cases. Cancer 2005; 103: 1201-1209. (Pubitemid 40328091)
6. Shiina S, Teratani T, Obi S, et al: A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-130.
7. Camma C, Di Marco V, Orlando A, et al: Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol 2005; 42: 535-540.
8. Lencioni RA, Allgaier HP, Cioni D, et al: Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-240.
9. Cioni D, Lencioni R, Rossi S, et al: Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power Doppler sonography to assess treatment outcome. AJR Am J Roentgenol 2001; 177: 783-788.
10. Lee HM, Lu DS, Krasny RM, et al: Hepatic lesion characterization in cirrhosis: significance of arterial hypervascularity on dualphase helical CT. AJR Am J Roentgenol 1997; 169: 125-130.
11. Mortele KJ, De Keukeleire K, Praet M, et al: Malignant focal hepatic lesions complicating underlying liver disease: dual-phase contrast- enhanced spiral CT sensitivity and specificity in orthotopic liver transplant patients. Eur Radiol 2001; 11: 1631-1638.
12. Koda M, Ueki M, Maeda Y, Mimura K, Okamoto K, Matsunaga Y, et al: Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm. Am J Roentgenol 2004; 183: 538-588.
13. Minami Y, Chung H, Kudo M, Kitai S, Takahashi S, Inoue T, Ueshima K, Shiozaki H: Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation. AJR Am J Roentgenol 2008; 190:W335-W341.
14. Lim HK, Choi D, Lee WJ, et al: Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology 2001; 221: 447-454.
15. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS: Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210: 655-661.
16. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, et al: Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000; 214: 761-768.
17. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC: Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005; 54: 1151-1156.
18. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, et al: A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129: 122-130.
19. Brunello F, Veltri A, Carucci P, Pagano E, Ciccone G, Moretto P, et al: Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol 2008; 43: 727-735.
20. Cho YK, Kim JK, Kim MY, Rhim H, Han JK: Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009; 49: 453-459.
21. Ogawa T, Kawamoto H, Kobayashi Y, Nakamura S, Miyatake H, Harada R, Tsutsumi K: Prevention of biliary complication in radiofrequency ablation for hepatocellular carcinoma - cooling effect by endoscopic nasobiliary drainage tube. Eur J Radiol 2010; 73: 385-390.
22. Minami Y, Kudo M, Chung H, et al: Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. AJR Am J Roentgenol 2007; 188: 489-494.
23. Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y, Fujishima T, Yoshida H, Kawabe T, Omata M: Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103: 1201-1209. (Pubitemid 40328091)
24. Komorizono Y, Oketani M, Sako K, Yamasaki N, Shibatou T, Maeda M, Kohara K, Shigenobu S, Ishibashi K, Arima T: Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 2003; 97: 1253-1262.
25. Myreng Y, Molstad P, Ytre-Arne K, et al: Safety of the transpulmonary ultrasound contrast agent NC100100: a clinical and haemodynamic evaluation in patients with suspected or proved coronary artery disease. Heart 1999; 82: 333-335.
26. Yanagisawa K, Moriyasu F, Miyahara T, Yuki M, Iijima H: Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 2007; 33: 318-325.